Markets › Pakistan › KAR › ABOT

Abbott Laboratories (Pakistan) Ltd

KAR:ABOTHealth TechnologyPSX:ALLSHRPSX:KMIALLSHR

Rs 947.72+0.35%LiveIn session · ≈ AED 12.58 · Market cap $331.56M · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	32.0%	36.1%	28.2%	20.4%	27.7%	33.5%	+5.8 pts
Operating margin	16.2%	19.1%	12.4%	3.5%	12.3%	16.7%	+4.5 pts
Net margin	12.9%	14.0%	6.1%	0.5%	7.7%	10.6%	+2.9 pts
EBITDA margin	19.5%	22.0%	15.3%	6.4%	14.9%	19.2%	+4.4 pts
Return on equity	29.1%	34.4%	17.6%	1.4%	22.1%	25.2%	+3.1 pts
Return on assets	18.2%	20.7%	8.8%	0.7%	13.8%	16.8%	+3.0 pts
Return on capital employed	31.7%	41.7%	31.0%	9.6%	31.8%	37.0%	+5.2 pts
Debt / equity	0.1×	0.0×	0.0×	0.0×	0.0×	0.0×	+600.9%
Debt / assets	3.3%	0.8%	0.7%	0.4%	0.1%	1.0%	+0.9 pts
Interest coverage	74.6×	131.5×	188.4×	64.2×	353.8×	166.8×	−52.8%
Current ratio	2.3×	2.0×	1.5×	1.4×	2.0×	2.3×	+16.1%
Quick ratio	1.5×	1.2×	0.8×	0.6×	1.0×	1.3×	+38.5%
Cash ratio	0.1×	0.1×	0.5×	0.3×	0.5×	1.0×	+88.1%
Asset turnover	1.4×	1.5×	1.4×	1.5×	1.8×	1.6×	−11.6%
Inventory turnover	4.2×	3.6×	3.5×	3.2×	4.1×	3.8×	−7.3%
Receivables turnover	24.2×	24.1×	17.6×	14.7×	16.0×	19.3×	+20.5%
Dividend payout	48.5%	73.7%	33.8%	525.0%	19.7%	12.2%	−7.5 pts